These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25881295)

  • 1. MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3.
    Liang H; Yan X; Pan Y; Wang Y; Wang N; Li L; Liu Y; Chen X; Zhang CY; Gu H; Zen K
    Mol Cancer; 2015 Mar; 14():58. PubMed ID: 25881295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor.
    Pan Y; Liang H; Liu H; Li D; Chen X; Li L; Zhang CY; Zen K
    J Immunol; 2014 Jan; 192(1):437-46. PubMed ID: 24307738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
    Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
    Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-452 promotes the development of gastric cancer via targeting EPB41L3.
    He X; Shu Y
    Pathol Res Pract; 2020 Jan; 216(1):152725. PubMed ID: 31734055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
    Wang X; Chen Z
    Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated fatty acids modulate the delivery of platelet microvesicle-derived microRNAs into human breast cancer cell lines.
    Gasperi V; Vangapandu C; Savini I; Ventimiglia G; Adorno G; Catani MV
    J Nutr Biochem; 2019 Dec; 74():108242. PubMed ID: 31665654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
    Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
    Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
    Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
    Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
    Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
    BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
    Ma Y; Li X; Cheng S; Wei W; Li Y
    Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.